Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists

Journal of Thrombosis and Thrombolysis

Volumn 9, Issue 1, 2000, Pages 23-28

  Rebella, Sam S ^a   Huang, Jinbao ^a   Faul, Jessica D ^a   Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

GPIIb IIIa; Platelet aggregation; PPACK (Phe Pro Arg chloromethyl ketone); Trisodium citrate

Indexed keywords

3 [3 (4 AMIDINOBENZAMIDO)PROPIONAMIDO] 2 (4 ETHYLBENZENESULFONAMIDO)PROPIONIC ACID; ABCIXIMAB; ADENOSINE DIPHOSPHATE; CALCIUM ION; CITRATE TRISODIUM; CYCLO(DEXTRO 2 AMINOBUTYRYL 2 N METHYLARGINYLGLYCYLASPARTYL 3 AMINOMETHYLBENZOIC ACID) METHANESULFONATE; FIBRINOGEN RECEPTOR ANTAGONIST; TIROFIBAN; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; CHELATION; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; HUMAN; HUMAN CELL; HYPOCALCEMIA; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RICH PLASMA;

EID: 0033960084     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1018679708251     Document Type: Article

References (33)

1. White JG. Effects of ethylenediamine tetracetic acid (EDTA) on platelet structure. Scand J Haematol 1968;5: 241-254.
2. Pidard D, Didry D, Kunicki TJ, Nurden AT. Temperature-dependent effects of EDTA on the membrane glycoprotein IIb-IIIa complex and platelet aggregability. Blood 1986;67: 604-611.
3. Shattil SJ, Brass LF, Bennett JS, Pandhi P. Biochemical and functional consequences of dissociation of the platelet membrane glycoprotein IIb-IIIa complex. Blood 1985;66:92-98.
4. Fujimura K, Philips DR. Calcium cation regulation of glycoprotein IIb-IIIa complex formation in platelet plasma membranes. J Biol Chem 1983;258:10247-10252.
5. +2;-dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complex. J Biol Chem 1989;264:13102-13108.
6. Marguerie GA, Edgington TS, Plow EF. Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem 1980;255:154-161.
7. Dandona P, Thusu K, Khurana U, Love J, Aljada A, Mousa S. Calcium, calmodulin and protein kinase C dependence of platlet shape change. Thromb Res 1996;81:163-175.
8. Lefkovitz J, Plow EF, Topol EJ. Platelet glycopotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332:1553-1559.
9. Lanza F, Stierle A, Gachet C, Cazenave JP. Differential effects of extra and intracellular calcium chelation on human platelet function and glycoprotein IIb/IIIa complex stability. Nouv Rev Fr Hematol 1992;34:123-131.
10. Heidenreich R, Eisman R, Delgrosso K, Surrey S, Bennett JS, Schwartz E, Poncz M. Organization of the gene for platelet glycoprotein lib. Biochemistry 1990;29:1232-1244.
11. Kieffer N, Phillips DR. Platelet membrane glycoproteins: Functions in cellular interactions. Annu Rev Cell Biol 1990;6:329-357.
12. Lee JO, Rieu P, Arnaout MA, Liddington R. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell 1995;80:631-638.
13. Loftus JC, O'Toole TE, Plow EF, Glass A, Frelinger AL, Ginsberg MH. A beta 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science 1990;249:915-918.
14. Tozer EC, Liddington RC, Sutcliffe MJ, Smeeton AH, Loftus JC. Ligand binding to integrin alpha II beta3 is dependent on a MIDAS-like domain in the beta3 subunit. J Biol Chem 1996;271:21978-21984.
15. D'souza SE, Haas TA, Piotrowicz RS, et al. Ligand and cation binding are dual functions of a discrete segment of the integrin β3 subunit: Cation displacement is involved in ligand binding. Cell 1994;79:659-667.
16. Hu DD, Barbas CF, Smith JW. An allosteric Ca2+ binding site on the beta3-integrins that regulates the dissociation rate for RGD ligands. J Biol Chem 1996;271:21745-21751.
17. Rebello SS, Driscoll EM, Lucchesi BR. TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog. Stroke 1997;28:1-8.
18. Collen D, Lu HR, Stassen JM, Vreys I, Yasuda T, Bunting S, Gold HK. Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis. Thromb Haemost 1994;71:95-102.
19. Philips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb/IIIa complex. Blood 1988;71: 831-843.
20. Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979;254:5357-5363.
21. Mustard JF, Packham MA, Kinlough-Rathbone RL, Perry DW, Regoeczi E. Fibrinogen and ADP-induced platelet aggregation. Blood 1978;52:453-466.
22. Peerschke EI, Zucker MB, Grant R A, Egan JJ, Johnson MM. Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood 1980;55:841-847.
23. Lam SC. Isolation and characterization of a chymotryptic fragment of platelet glycoprotein IIb/IIIa retaining Arg-Gly-Asp binding activity. J Biol Chem 1992;267:5649-5655.
24. Zucker MB, Grant RA. Nonreversible loss of platelet aggregability induced by calcium deprivation. Blood 1978;52: 505-514.
25. 2+. Blood 1990;76: 1546-1557.
26. Rote WE, Nedelman MA, Mu DX, Manley PJ, Weisman H, Cunningham MR, Lucchesi BR. Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys. Stroke 1994;25:1223-1233.
27. Lynch JJ, Cook JJ, Sitko GR, et al. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383. J Pharmacol Exp Ther 1995;272:20-32.
28. Cook JJ, Sitko G R, Holahan MA, et al. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. J Pharmacol Exp Ther 1997;281:677-689.
29. Rote WE, Werns SW, Davis JH, Feigen LP, Kilgore KS, Lucchesi BR. Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery. Cardiovascular Res 1993;27:500-507.
30. Rebello SS, Huang J, Saito K, Lucchesi BR. The in vivo efficacy of SM-20302, a GPIIb/IIIa receptor antagonist, correlates with ex vivo platelet inhibition in heparinized blood but not in citrated blood. Arterioscl Thromb Vase Biol 1998, accepted.
31. Ohman EM, Harrington RA, Lincoff AM, Kitt MM, Kleiman NS, Tcheng JE. Early clinical experience with integrilin, an inhibitor of the platelet glycoprotein IIb/IIIa Ha integrin receptor. Eur Heart J 1995;16(Suppl. L):50-55.
32. Resar JR, Brinker JA, Gerstenblith G, Blumenthal RS, Dudek A, Coombs VJ, Goldschmidt-Clermont PJ. Disparity of Integrilin inhibition of platelet aggregation and GP II/IIIa fibrinogen binding in angioplasty patients. Circulation 1996;94(Suppl. I):1-98.
33. 2+ on GPIIb-IIIa interactions with Integrilin. Circulation 1997;96:1488-1494.